The EMPOWER Study: Endometriosis Diagnosis Using MicroRNA

Active, not recruitingOBSERVATIONAL
Enrollment

750

Participants

Timeline

Start Date

November 2, 2020

Primary Completion Date

May 3, 2023

Study Completion Date

December 31, 2024

Conditions
Endometriosis
Trial Locations (23)

10019

NewYork-Presbyterian / Columbia University Medical Center, New York

15213

University of Pittsburgh Medical Center, Pittsburgh

17033

Penn State Health, Hershey

19104

Hospital of the University of Pennsylvania, Philadelphia

19713

Christiana Care, Newark

RAD Fertility, Newark

20010

MedStar Washington Hospital Center, Washington D.C.

21205

Johns Hopkins University, Baltimore

30328

Academia of Women's Health and Endoscopic Surgery, Atlanta

33606

University of South Florida, Tampa

40202

University of Louisville Hospital, Louisville

44106

University Hospitals, Cleveland

44195

Cleveland Clinic, Cleveland

60068

The Advanced Gynecologic Surgery Institute, Park Ridge

60201

NorthShore University HealthSystem, Evanston

60611

Northwestern Medicine, Chicago

73104

University of Oklahoma Health Sciences Center, Oklahoma City

78712

UT Austin, Austin

94031

Stanford University Hospital, Palo Alto

94061

Center for Special Minimally Invasive & Robotic Surgery, Woodside

98109

Seattle Reproductive Medicine, Seattle

06510

Yale University, New Haven

08901

Rutgers Robert Wood Johnson University Hospital, New Brunswick

Sponsors
All Listed Sponsors
lead

Dot Laboratories, Inc.

INDUSTRY

NCT04598698 - The EMPOWER Study: Endometriosis Diagnosis Using MicroRNA | Biotech Hunter | Biotech Hunter